热门资讯> 正文
NewcelX GAAP每股收益为-0.96美元
2026-09-19 04:26
- NewcelX press release (NCEL): 1H GAAP EPS of -$0.96.
- As of June 30, 2026, the company’s total equity was positive at $6,041, including cash and cash equivalents of $710.
More on NLS Pharmaceutics
- Historical earnings data for NLS Pharmaceutics
- Financial information for NLS Pharmaceutics
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。